Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
Top Cited Papers
Open Access
- 1 October 2008
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 112 (7), 2687-2693
- https://doi.org/10.1182/blood-2008-03-147025
Abstract
Mantle cell lymphoma (MCL) is considered incurable. Intensive immunochemotherapy with stem cell support has not been tested in large, prospective serKeywords
This publication has 37 references indexed in Scilit:
- Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)Blood, 2006
- Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell LymphomaTransplantation and Cellular Therapy, 2006
- The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphomaBlood, 2006
- Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL NetworkBritish Journal of Haematology, 2005
- Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL NetworkBlood, 2005
- Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remissionCancer, 2003
- A Danish population-based analysis of 105 mantle cell lymphoma patientsEuropean Journal Of Cancer, 2002
- Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study GroupAmerican Journal of Hematology, 2000
- High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experienceBone Marrow Transplantation, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958